Ernexa Therapeutics (ERNA) vs Jupiter Neurosciences (JUNS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Ernexa Therapeutics is the larger company by market cap ($3.9 million vs $3.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ERNA | JUNS |
|---|---|---|
| Share price | $2.39 | $2.84 |
| Market cap | $3.90M | $3.74M |
| 1-day change | +6.94% | -0.70% |
| Forward P/E | — | 47.33 |
| EPS (TTM) | $-14.03 | $-18.94 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $71.50 | $135.75 |
| 52-week low | $2.15 | $2.25 |
| Distance from 52-week high | -96.66% | -97.91% |
| Average volume | 462.76K | 997.52K |
| Shares outstanding | 1.63M | 1.32M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ERNA vs JUNS FAQ
Which is bigger, Ernexa Therapeutics or Jupiter Neurosciences?
Ernexa Therapeutics (ERNA) is larger, with a market capitalization of $3.90M compared with $3.74M for Jupiter Neurosciences (JUNS).
Are Ernexa Therapeutics and Jupiter Neurosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.